Regeneron Pharmaceuticals
REGN
#292
Rank
S$107.21 B
Marketcap
S$1,041
Share price
-0.35%
Change (1 day)
23.03%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): S$6.65 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$15.53 Billion. In 2025 the company made an earning of S$6.69 Billion, an increase over its 2024 earnings that were of S$6.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$6.65 B-0.57%
2025 S$6.69 B9.43%
2024 S$6.12 B13.83%
2023 S$5.37 B-13.57%
2022 S$6.22 B-47.9%
2021 S$11.94 B144.75%
2020 S$4.87 B56.86%
2019 S$3.11 B-4.87%
2018 S$3.26 B22.86%
2017 S$2.66 B56.3%
2016 S$1.70 B8.55%
2015 S$1.56 B54.53%
2014 S$1.01 B11.14%
2013 S$0.91 B72.13%
2012 S$0.53 B-285.93%
2011 -S$0.29 Billion121.73%
2010 -S$0.13 Billion37.18%
2009 -S$93.84 Million-14.6%
2008 -S$0.11 Billion-25.02%
2007 -S$0.15 Billion6.32%
2006 -S$0.14 Billion-186.52%
2005 S$0.15 B2103.7%
2004 S$7.22 M-105.66%
2003 -S$0.13 Billion-18.18%
2002 -S$0.16 Billion42.33%
2001 -S$0.11 Billion129.35%
2000 -S$47.84 Million51.87%
1999 -S$31.5 Million92.19%
1998 -S$16.4 Million66.23%
1997 -S$9.86 Million-55.49%
1996 -S$22.16 Million103.53%
1995 -S$10.89 Million-70.89%
1994 -S$37.39 Million-26.08%
1993 -S$50.58 Million114.67%
1992 -S$23.57 Million196.77%
1991 -S$7.94 Million87.88%
1990 -S$4.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B 407.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.87 B 200.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$13.17 B 99.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.16 B 38.60%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$1.29 B-80.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.44 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA